Economic burden of psoriasis in Germany

[Fred]

This study looked at the economic burden of psoriasis in German patients.

Quote:

---

Background:
Though psoriasis poses a substantial chronic socio-economic burden, few studies have addressed the economic impact in Germany.

Objectives:
The objective was to evaluate the annual costs of psoriasis in Germany from the societal perspective.

Methods:
A cross-sectional study was performed in randomly selected German dermatology practices and clinics in 2013/2014 using standardized questionnaires of illness-related costs. Costs were grouped by perspective and category as well as analysed by sex and age. Group differences were tested by non-parametric tests.

Results:
Complete data were obtained from 1158 patients in 132 centres. Annual average costs for patients with psoriasis: total costs € 5543 ± € 8044, systemic treatment costs (paid by the statutory health insurances [SHI]) € 3733 ± € 7322, out-of-pocket costs € 224 ± € 406, total SHI costs € 4940 ± € 7533, direct costs € 5164 ± € 7581 and indirect costs € 379 ± € 2087. Significant higher costs in male and significant lower costs in 65+-year-old patients were found.

Conclusions:
Psoriasis induces a considerable economic burden. Between 2003 and 2014, costs have markedly shifted from hospital, out-of-pocket and indirect costs towards systemic drug costs.

Source: onlinelibrary.wiley.com

#Funded by: Biogen, Ismaning, Germany

[Turnedlight]

Surely it’s always more expensive to have people in hospital than even the pricy drugs?

[jiml]

Surely it’s always more expensive to have people in hospital than even the pricy drugs?

Yes I'm sure it is but if you notice one of the funders is Biogen who makes Fumaderm ...so I guess they are making a point that the German dermatologists should be prescribing their affordable drug

[Caroline]

Surely it’s always more expensive to have people in hospital than even the pricy drugs?

Yes I'm sure it is but if you notice one of the funders is Biogen who makes Fumaderm ...so I guess they are making a point that the German dermatologists should be prescribing their affordable drug

But they now have competition in Europe.

[jiml]

Surely it’s always more expensive to have people in hospital than even the pricy drugs?

Yes I'm sure it is but if you notice one of the funders is Biogen who makes Fumaderm ...so I guess they are making a point that the German dermatologists should be prescribing their affordable drug

But they now have competition in Europe.

Yes you are right, even more reason to carry out this study ... keeping their name in front of prescribers

[Caroline]

Surely it’s always more expensive to have people in hospital than even the pricy drugs?

Yes I'm sure it is but if you notice one of the funders is Biogen who makes Fumaderm ...so I guess they are making a point that the German dermatologists should be prescribing their affordable drug

But they now have competition in Europe.

Yes you are right,  even more reason to carry out this study ... keeping their name in front of prescribers

Lower the price, that is how they do that on the market...

[Bill]

They could buy DMF by the tonne from China and treat people for peanuts. Why don't they do this.

[Caroline]

They could buy DMF by the tonne from China and treat people for peanuts. Why don't they do this.

Mmmm, what if I were a pharmacist and I wanted to earn money? You must know that is one of the drivers of pharmacy. Earning money.
It would work with a cheap medication and lots of patients, e.g. that one on two people would use it, like aspirin and paracetamol. But now we only have a cheap medication and a relatively handful of patients... what to do?
I have it !!! Let's just raise the price!  We have the government with all its rules and guidelines at our side, so this should work. So it becomes easy to lift the price of a 0,02 cents medication for at least a thousand fold..  

It is also the problem with my treatment, it is way too cheap...

Next question: "Does the human race use it's brain adequately ?"